BGIM
HRMY icon

Brandywine Global Investment Management’s Harmony Biosciences HRMY Stock Holding History

Brandywine Global Investment Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.21M Sell
85,722
-60,482
-41% -$1.99M 0.02% 429
2025
Q3 		$4.03M Buy
+146,204
New +$5.04M 0.03% 401

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Brandywine Global Investment Management's HRMY Position: Q4 2025 in Review

Brandywine Global Investment Management reduced its Harmony Biosciences (HRMY) stake by 41% in Q4 2025, selling an estimated $1.99M and leaving 85,722 shares worth $3.21M. The position accounts for 0.02% of the portfolio, ranked #429.

Brandywine Global Investment Management first reported a position in HRMY in Q3 2025 and has held it in 2 quarters since. The position peaked at $4.03M in Q3 2025. 323 funds tracked by Wall St. Rank hold HRMY as of Q4 2025.

  • Brandywine Global Investment Management held 85,722 shares of Harmony Biosciences worth $3.21M as of Q4 2025.
  • Brandywine Global Investment Management sold 60,482 Harmony Biosciences shares in Q4 2025, an estimated $1.99M.
  • Harmony Biosciences made up 0.02% of Brandywine Global Investment Management's portfolio in Q4 2025, its #429 holding.
  • Brandywine Global Investment Management first reported a position in Harmony Biosciences in Q3 2025 and has held it in 2 quarters since.
  • Brandywine Global Investment Management's Harmony Biosciences position peaked at $4.03M in Q3 2025.
  • 323 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2025.

Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.